Pseudoprolines (psiPro) in drug design: direct insertion of psiPro systems into cyclosporin C.
M Keller, T Wöhr, P Dumy, L Patiny, M Mutter
Index: Chemistry 6(23) , 4358-63, (2000)
Full Text: HTML
Abstract
The insertion of acetals that exhibit variable structural features into complex peptides such as cyclosporin C (CsC) results in oxazolidine derivatives (pseudoprolines, psiPro) of tailored physico-chemical and biological properties. N,O-Acetalation of the 2-threonine hydroxyl group and the preceding amide nitrogen of CsC is achieved by treating the molecule with a number of both arylated and non-arylated dimethyl acetals. The psiPro-containing CsC derivatives exhibit enhanced conformational backbone rigidity, as suggested by analytical HPLC, NMR spectroscopy and by kinetic measurements on binding with their receptor protein cyclophilin A (CypA) that were not time-dependent. IC50 values for calf-thymus CypA were obtained by kinetic evaluation of its cis-->trans isomerase activity. The choice of the para-substituted aryl dimethyl acetals allows the inhibitory properties of the corresponding derivatives to be modulated to either prodrugs or moderately strongly binding cyclosporin C derivatives.
Related Compounds
Related Articles:
1992-07-01
[Clin. Exp. Immunol. 89(1) , 136-42, (1992)]
Tachykinin antagonists screening from microbial origin.
1996-01-01
[J. Antibiot. 49(1) , 110-2, (1996)]
Monitoring cyclosporine by HPLC with cyclosporin C as internal standard.
1993-01-01
[Clin. Chem. 39(1) , 168, (1993)]
1986-03-01
[Clin. Chem. 32(3) , 492-5, (1986)]
2003-07-01
[J. Heart Lung Transplant. 22(7) , 715-22, (2003)]